ARTQX | JVMTX | ARTQX / JVMTX | |
Total Expense Ratio | 1.17 | 1.00 | 117% |
Annual Report Gross Expense Ratio | 1.17 | 1.11 | 105% |
Fund Existence | 24 years | 12 years | - |
Gain YTD | -0.577 | 6.429 | -9% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.03B | 22.2B | 5% |
Annual Yield % from dividends | 0.48 | 0.65 | 75% |
Returns for 1 year | -5.17 | -3.72 | 139% |
Returns for 3 years | -14.36 | 21.93 | -65% |
Returns for 5 years | 0.43 | 54.11 | 1% |
Returns for 10 years | -34.23 | 42.61 | -80% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SAGP | 32.89 | 0.16 | +0.49% |
Strategas Global Policy Opp ETF | |||
IWB | 343.04 | 1.27 | +0.37% |
iShares Russell 1000 ETF | |||
TOK | 126.70 | 0.32 | +0.25% |
iShares MSCI Kokusai ETF | |||
FFC | 16.50 | N/A | N/A |
Flaherty & Crumrine Preferred and Income Securities Fund | |||
BIS | 15.96 | -0.57 | -3.45% |
ProShares UltraShort Nasdaq Biotech |